menu search

Revolution medicines to present preclinical data at the upcoming american association for cancer research annual meeting 2023

REDWOOD CITY, Calif., April 06, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targe...

April 6, 2023, 7:00 am

Why shares of morphosys are up wednesday

MorphoSys had said it planned to cut preclinical programs and trim its workforce. The company said it e...

April 5, 2023, 2:34 pm

Voyager: preclinical company with major big pharma deals

Voyager is a preclinical company with multibillion dollar big pharma deals. Its core asset is its TRACE...

April 2, 2023, 9:32 am

Ibio advances anti-ccr8 antibody program to preclinical in vivo testing

– Immuno-oncology candidate discovered using iBio’s AI epitope steering platform – – Expands Treg depletion franchise beyond IBIO-101 – BRYA...

March 31, 2023, 12:10 pm

Molecular templates, inc. reports fourth quarter 2022 financial results and business update

Announces strategic reprioritization to focus on clinical development of MT-6402, MT-8421, and MT-0169, and pr...

March 30, 2023, 10:10 pm

Xeris biopharma announces research evaluation collaboration and option agreement with regeneron for xeriject

Xeris Biopharma Holdings (NASDAQ:XERS) told investors it has entered into a platform research evaluation collaboration and option agreement with Regen...

March 30, 2023, 11:31 am

Betterlife pharma says betr-001 drug candidate featured in drug discovery & development article

BetterLife Pharma Inc (CSE:BETR, OTCQB:BETRF) has announced that an article titled “Non-hallucinogenic LSD derivative reduces depression symptoms in...

March 29, 2023, 9:31 am

Gain therapeutics to present positive preclinical data on its gba1 program at the ad/pd 2023 meeting

Study results support the disease-modifying potential of structurally targeted allosteric regulators of GCase for the treatment of Alzheimer's disease...

March 29, 2023, 8:52 am

Ambrx to present preclinical data on arx517 and arx305 at the 2023 aacr annual meeting

Three posters will be presented at AACR and include data from preclinical studies of ARX517 and ARX305 ...

March 27, 2023, 8:30 am

Pepgen inc (pepg) q4 2022 earnings call transcript

PepGen Inc (NASDAQ:PEPG ) Q4 2022 Earnings Conference Call March 23, 2023 4:30 PM ET Company Participants Noel Donnelly - Chief Financial Officer Jame...

March 25, 2023, 10:58 am

Invivyd, inc (ivvd) q4 2022 earnings call transcript

Invivyd, Inc (NASDAQ:IVVD ) Q4 2022 Earnings Conference Call March 23, 2023 4:30 PM ET Company Participants Kyra Faircloth - Investor Relations Dave H...

March 25, 2023, 10:49 am

Imunon to hold fourth quarter 2022 financial results and business update conference call on thursday, march 30, 2023

LAWRENCEVILLE, N.J., March 23, 2023 (GLOBE NEWSWIRE) -- IMUNON , Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing ...

March 23, 2023, 8:30 am

Kineta to present vista biomarker data at aacr annual meeting 2023

SEATTLE, March 22, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immu...

March 22, 2023, 6:30 am

Relief therapeutics to present pre-clinical evidence for improved amino acid utilization with pku golike at the society for inherited metabolic disorders 44th annual meeting

The results of the preclinical study demonstrate improved muscle anabolism and function with a prolonge...

March 17, 2023, 6:25 pm

Celcuity to present preclinical data on therapeutic effects of gedatolisib in gynecological cancer models at aacr annual meeting 2023

MINNEAPOLIS, MN / ACCESSWIRE / March 15, 2023 / Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company focused on development of targeted...

March 15, 2023, 7:35 pm

Context therapeutics says ctim-76 abstract accepted for presentation at aacr annual meeting

Context Therapeutics (NASDAQ:CNTX) Inc announced that an abstract regarding its preclinical candidate, ...

March 15, 2023, 9:16 am

Theratechnologies to present preclinical data at aacr demonstrating synergy between th1902 and anti-pd-l1 immunotherapy in cold tumor model

MONTREAL, March 14, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biophar...

March 14, 2023, 6:42 pm

Crispr therapeutics to present at the american association for cancer research 2023 annual meeting

ZUG, Switzerland and BOSTON, March 14, 2023 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating t...

March 14, 2023, 6:02 pm

Nuvalent to present new preclinical data on alk-selective inhibitor nvl-655 at aacr annual meeting 2023

CAMBRIDGE, Mass. , March 14, 2023 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating preci...

March 14, 2023, 5:59 pm

Cullinan oncology to present new preclinical data for cln-619 and cln-617 at the 2023 american association for cancer research annual meeting

CLN-619 is a MICA/B directed humanized IgG1 antibody being studied in a global Phase 1 clinical trial in patients with advanced solid tumors. Initial ...

March 14, 2023, 4:35 pm


Search within

Pages Search Results: